Qnovia's Inhaled Nicotine Replacement Therapy Delivers Positive Results in First Human Study
PR Newswire —
RespiRx ™ achieves cigarette-comparable nicotine delivery with favorable safety profile, marking first major advancement in smoking cessation in decades IRVINE, Calif., Feb. 10, 2026 /PRNewswire/ -- Qnovia, Inc., a pharmaceutical and medtech company revolutionizing inhaled therapeutics,...